Using quitlines to spread lung cancer screening information to people who smoke
Official title: Leveraging tobacco quitlines to disseminate lung cancer screening educational materials for persons who smoke
Funded at University of Tx Md Anderson Can Ctr · NIH-11425785 · Data updated 2026-11-12
A large cancer center project will test two ways of delivering lung cancer screening information to adults who smoke, using quitlines as a trusted channel to reach them.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project start | August 1, 2026 |
| Project end | July 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $667,282 |
| NIH project number | 1R01CA315499-01 |
| Project ID | NIH-11425785 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults 21+ who smoke and are eligible for lung cancer screening, engaged with quitlines.
✕Less likely to help
Individuals who do not smoke or who are not in the eligible screening window may not benefit from the messaging approach.
What this research studies
This project partners with tobacco quitlines to share clear information about lung cancer screening and the decisions involved with getting screened. It will compare a low-touch approach with a high-touch approach to see which more effectively increases awareness and interest in screening among eligible adults. Participants include adults 21 and older who smoke and are engaged with quitline services, with real-world implementation in the community setting. The study aims to integrate counseling and shared decision-making into the screening process through existing quitline infrastructure.
Why it matters
Potential benefit: If successful, the project could lead to higher screening rates and earlier detection of lung cancer among people who smoke.
How similar studies have gone: Previous work suggests public health outreach via existing tobacco cessation channels can reach high-risk groups effectively, though direct comparisons of dissemination strategies are needed.
Where this research is happening
-
University of Tx Md Anderson Can Ctr
Houston, United States Active
Researchers
- Principal investigator: Lowenstein, Lisa Marie — University of Tx Md Anderson Can Ctr
- Study coordinator: Lowenstein, Lisa Marie
Related research
Other NIH-funded projects on the same topics.
-
Digital health strategies to expand lung cancer screening in safety-net clinics
A funded project aims to help low-resource clinics increase the use of lung cancer screening for patients who smoke or are at risk.
-
Integrated approach to lung screening and quitting for African Americans
A multi-level program aims to boost LDCT lung cancer screening uptake and help African American smokers quit, with support from a comprehensive community-focused plan.
-
Population health approach to boost lung cancer screening at community clinics
A large Utah project aims to help community clinics reach more eligible adults to get low-dose CT lung cancer screening.
-
Group-based tobacco treatment for older adults after lung cancer screening
A study tests a group-based tobacco cessation program for older adults who are getting lung cancer screening to help them quit smoking.
-
Personalized Lung Cancer Screening for Veterans
Aimed at improving who gets screened and how lung cancer is diagnosed among Veterans using personalized tools.
-
Proteogenomic framework to improve lung cancer screening with biomarkers
A biomarker-based approach aims to refine LDCT lung cancer screening so more cancers are caught early while reducing unnecessary procedures.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.